Predicting outcomes in esophageal adenocarcinoma following neoadjuvant chemoradiation: Interactions between tumor response and survival
Authors:
- 14 November 2023
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 168 (1) , 278-289.e4
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized TrialTargeted Oncology, 2017
- Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive ChemoradiationJournal of Thoracic Oncology, 2017
- Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trialThe Lancet Oncology, 2015
- Signet Ring Cells in Esophageal Adenocarcinoma Predict Poor Response to Preoperative ChemoradiationThe Annals of Thoracic Surgery, 2014
- Adenocarcinoma of the Esophagus With Signet Ring Cell Features Portends a Poor PrognosisThe Annals of Thoracic Surgery, 2013
- Complete Metabolic Response Is Not Uniformly Predictive of Complete Pathologic Response After Induction Therapy for Esophageal CancerThe Annals of Thoracic Surgery, 2013
- PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trialThe Lancet Oncology, 2007
- Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinomaJournal of Surgical Oncology, 2005
- Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiationCancer, 2005
- Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlationsCancer, 1994